FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea
The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...
Lilly Obesity Drug Gets First US Approval for Sleep Apnea
Eli Lilly & Co.’s weight-loss shot Zepbound won approval in the US as the first drug to treat sleep apnea, opening the door ...
The popular weight-loss drug Zepbound can now be used to treat sleep apnea
The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...
Lilly's weight-loss drug Zepbound wins US FDA approval for sleep apnea
The regulator approved the drug for moderate to severe obstructive sleep apnea in adults with obesity, the company said. "Too ...
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
Honolulu Star-Advertiser16m
New weight-loss treatment becomes first FDA-approved drug for sleep apnea
The Food and Drug Administration today approved Eli Lilly’s weight-loss treatment, Zepbound, for obstructive sleep apnea, ...
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
The Globe and Mail9m
Stock market today: Wall Street rises to turn a dismal week into just a bad one
A stumble for its rival could benefit Eli Lilly, whose Zepbound helps treat obesity. All told, the S&P 500 rose 63.77 points to 5,930.85. The Dow Jones Industrial Average gained 498.02 to 42,840.26, ...